Dai R, Zhai S, Wei X, Pincus M R, Vestal R E, Friedman F K
Laboratory of Molecular Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892, USA.
J Protein Chem. 1998 Oct;17(7):643-50. doi: 10.1007/BF02780965.
Cytochrome P450 1A2 metabolizes a number of important drugs, procarcinogens, and endogenous compounds. Several flavones, a class of phytochemicals consumed in the human diet, have been shown to differentially inhibit human P450 1A2-mediated methoxyresorufin demethylase. A molecular model of this P450 was constructed in order to elucidate the molecular basis of the P450-flavone interaction. Flavone and its 3,5,7-trihydroxy and 3,5,7-trimethoxy derivatives were docked into the active site to assess their mode of binding. The site is hydrophobic and includes several residues that hydrogen bond with substituents on the flavone nucleus. The binding interactions of these flavones in the modeled active side are consistent with their relative inhibitory potentials, namely 3,5,7-trihydroxylflavone > flavone > 3,5,7-trimethoxylflavone, toward P450 1A2-mediated methoxyresorufin demethylation.
细胞色素P450 1A2可代谢多种重要药物、前致癌物和内源性化合物。几种类黄酮是人类饮食中摄入的一类植物化学物质,已被证明能不同程度地抑制人P450 1A2介导的甲氧基试卤灵脱甲基酶。构建了该P450的分子模型,以阐明P450与类黄酮相互作用的分子基础。将黄酮及其3,5,7-三羟基和3,5,7-三甲氧基衍生物对接至活性位点,以评估它们的结合模式。该位点具有疏水性,包含几个与黄酮核上取代基形成氢键的残基。这些黄酮在模拟活性位点的结合相互作用与其对P450 1A2介导的甲氧基试卤灵脱甲基化的相对抑制潜力一致,即3,5,7-三羟基黄酮>黄酮>3,5,7-三甲氧基黄酮。